Chase Investment Counsel’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-16,457
| Closed | -$1.82M | – | 110 |
|
2019
Q1 | $1.82M | Buy |
16,457
+630
| +4% | +$69.5K | 0.93% | 36 |
|
2018
Q4 | $1.46M | Sell |
15,827
-1,158
| -7% | -$106K | 0.87% | 37 |
|
2018
Q3 | $1.87M | Buy |
16,985
+282
| +2% | +$31.1K | 0.96% | 38 |
|
2018
Q2 | $1.56M | Sell |
16,703
-6,576
| -28% | -$614K | 0.84% | 37 |
|
2018
Q1 | $1.93M | Buy |
23,279
+255
| +1% | +$21.2K | 1% | 37 |
|
2017
Q4 | $2.1M | Sell |
23,024
-930
| -4% | -$84.7K | 1.1% | 36 |
|
2017
Q3 | $1.82M | Sell |
23,954
-4,870
| -17% | -$371K | 0.96% | 37 |
|
2017
Q2 | $2.16M | Buy |
28,824
+2,976
| +12% | +$223K | 1.05% | 36 |
|
2017
Q1 | $1.69M | Buy |
25,848
+11,713
| +83% | +$764K | 0.81% | 39 |
|
2016
Q4 | $779K | Buy |
14,135
+4,255
| +43% | +$234K | 0.39% | 61 |
|
2016
Q3 | $558K | Buy |
+9,880
| New | +$558K | 0.25% | 73 |
|